Skip to main content

Prostate Cancer: Screening

Volume 474: debated on Wednesday 26 March 2008

To ask the Secretary of State for Health how many prostate screenings there were in (a) Tamworth and (b) Staffordshire in each of the last five years. (193625)

The national health service, including the South Staffordshire Primary Care Trust, does not operate a prostate cancer screening programme. There is currently insufficient evidence from any country in the world to show that screening would reduce deaths from prostate cancer. The Government are committed to introducing a national screening programme for prostate cancer if and when screening and treatment techniques are sufficiently well developed. The United Kingdom National Screening Committee keeps screening for prostate cancer under review.

The prostate cancer risk management programme was established in 2002 to ensure that men considering a prostate specific antigen (PSA) test are given information concerning the benefits, limitations and risks associated with having a test. Figures on the number of PSA tests taken as a result of the programme are not collected centrally.

To ask the Secretary of State for Health (1) what percentage of male prisoners eligible for prostate cancer screening have been screened in the last three years; (193634)

(2) what percentage of males eligible for prostate cancer screening have been screened in the last three years in England.

The national health service does not operate a prostate cancer screening programme. There is currently insufficient evidence from any country in the world to show that screening would reduce deaths from prostate cancer. The Government are committed to introducing a national screening programme for prostate cancer if and when screening and treatment techniques are sufficiently well developed. The United Kingdom national screening committee keeps screening for prostate cancer under review.

The prostate cancer risk management programme (PCRMP) was established in 2002 to ensure that men considering a prostate specific antigen (PSA) test are given information concerning the benefits, limitations and risks associated with having a test. Figures on the number of PSA tests taken as a result of the programme are not collected centrally.